Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.21M Buy
25,859
+2,549
+11% +$135K ﹤0.01% 997
2018
Q4
$1.1M Buy
23,310
+1,335
+6% +$70.6K ﹤0.01% 1021
2018
Q3
$1.41M Sell
21,975
-932
-4% -$58.8K ﹤0.01% 997
2018
Q2
$1.38M Buy
22,907
+6,563
+40% +$416K ﹤0.01% 1002
2018
Q1
$1.17M Sell
16,344
-3,126
-16% -$224K ﹤0.01% 1008
2017
Q4
$1.33M Buy
19,470
+59
+0.3% +$4.22K ﹤0.01% 1058
2017
Q3
$1.5M Sell
19,411
-2,573
-12% -$187K ﹤0.01% 1026
2017
Q2
$1.49M Sell
21,984
-3,136
-12% -$206K ﹤0.01% 1035
2017
Q1
$1.52M Buy
25,120
+5,830
+30% +$362K ﹤0.01% 1037
2016
Q4
$1.21M Buy
19,290
+1,365
+8% +$82.3K ﹤0.01% 1048
2016
Q3
$999K Sell
17,925
-2,505
-12% -$120K ﹤0.01% 1019
2016
Q2
$881K Buy
20,430
+1,123
+6% +$47.4K ﹤0.01% 1033
2016
Q1
$805K Sell
19,307
-7,682
-28% -$284K ﹤0.01% 1059
2015
Q4
$976K Buy
+26,989
New +$953K ﹤0.01% 1050

Other funds holding ITRI

OppenheimerFunds's ITRI Position: Q1 2019 in Review

OppenheimerFunds increased its Itron (ITRI) stake by 11% in Q1 2019, buying an estimated $135K and bringing the position to 25,859 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #997.

OppenheimerFunds first reported a position in ITRI in Q4 2015 and has held it in 14 quarters since. The position peaked at $1.52M in Q1 2017. 229 funds tracked by Wall St. Rank hold ITRI as of Q1 2019.

  • OppenheimerFunds held 25,859 shares of Itron worth $1.21M as of Q1 2019.
  • OppenheimerFunds bought 2,549 Itron shares in Q1 2019, an estimated $135K.
  • Itron made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #997 holding.
  • OppenheimerFunds first reported a position in Itron in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Itron position peaked at $1.52M in Q1 2017.
  • 229 funds tracked by Wall St. Rank held Itron as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.